Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial

P.S. Hall, D. Swinson, D.A. Cairns, J.S. Waters, R. Petty, C. Allmark, S. Ruddock, S. Falk, J. Wadsley, R. Roy, T. Tillett, J. Nicoll, S. Cummins, J. Mano, S. Grumett, Z. Stokes, K. Konstantinos-Velios, A. Chatterjee, A. Garcia, T. WaddellK. Guptal, N. Maisey, M. Khan, J. Dent, S. Lord, A. Crossley, E. Katona, H. Marshall, H.I. Grabsch, G. Velikova, P.L. Ow, C. Handforth, H. Howard, M.T. Seymour*, GO2 Trial Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Web of Science)
Original languageEnglish
Pages (from-to)869-877
Number of pages9
JournalJAMA Oncology
Volume7
Issue number6
DOIs
Publication statusPublished - 1 Jun 2021

Keywords

  • METASTATIC COLORECTAL-CANCER
  • ADVANCED GASTRIC-CANCER
  • ESOPHAGOGASTRIC JUNCTION
  • EUROPEAN-ORGANIZATION
  • REGRESSION-MODELS
  • 1ST-LINE THERAPY
  • ELDERLY-PATIENTS
  • II TRIAL
  • FLUOROURACIL
  • ADENOCARCINOMA

Cite this